Meet Gwyn Richardson, M.D.
Gwyn Richardson, JD, MD, F.A.C.O.G.
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
Present Title & Affiliation
Primary Appointment
Professor, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor (Adjunt), Gynecologic Oncology Department, Lyndon B. Johnson Hospital, Houston, Texas
Associate Professor, Gynecologic Oncology, The University of Texas MD Anderson HAL Center, League City, Texas
Associate Professor, Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor (Adjunct), Gynecologic Oncology Department, Lyndon B. Johnson Hospital, Houston, Texas
Frances Eastland Conally Professorship in Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Galveston, TX
Education & Training
Degree-Granting Education
| 2001 | University of Texas Medical School at Galveston, Galveston, Texas, US, MD |
| 1997 | University of Texas School of Law, Austin, Texas, US, Law, J.D |
| 1992 | Bryn Mawr College, Bryn Mawr, Pennsylvania, US, Political Science, BA |
Postgraduate Training
| 2016-2017 | Clinical Fellowship, LEAD (Leadership Education and Development), Association of American Medical Colleges, Washington D.C, Maryland |
| 2006-2009 | Clinical Fellowship, Obstetrics & Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas |
| 2001-2005 | Clinical Residency, Obstetrics & Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas |
Licenses & Certifications
| 2023 | DEA |
| 2015 | American Board of Obstetrics and Gynecology Gynecologic Oncology |
| 2011 | American Board of Obstetrics and Gynecology Obstetrics and Gynecology |
| 2006 | NPI |
| 2005 | Texas Medical Board |
| 1997 | State Bar of Texas |
Experience & Service
Faculty Academic Appointments
Associate Professor (Adjunct), Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, 2018 - 2025
Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024
Associate Professor with Tenure, University of Texas Medical Branch at Galveston, Galveston, TX, 2017 - 2018
Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, 2009 - 2017
Administrative Appointments/Responsibilities
Fellowship Program Associate Director, Gynecologic Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Center Medical Director, UTMB, Galveston, Texas, 2021 - 2025
Center Medical Director, League City Houston Area Location (HAL), The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Residency Program Associate Director, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston Residency Program, Galveston, TX, 2017 - 2020
Assistant Course Director, TIME curriculum, University of Texas Medical Branch at Galveston, Galveston, TX, 2016 - 2017
Course Director, Heart of Medicine: Being with Suffering, University of Texas Medical Branch at Galveston, Galveston, TX, 2016 - 2022
Associate Director, Physician Healer Track, University of Texas Medical Branch at Galveston, Galveston, TX, 2016 - 2021
Obstetrics and Gynecology Clerkship Co-Director, University of Texas Medical Branch at Galveston, Galveston, TX, 2014 - 2017
Medical Co-Director, UTMB Cancer Center at Victory Lakes, League City, TX, 2014 - 2018
Holder, Frances Eastland Conally Professorship in Gynecologic Oncology, Galveston, TX, 2012 - 2023
Medical Co-Director, UTMB Health RMCHP - McAllen, McAllen, TX, 2010 - 2013
Medical Co-Director, UTMB Gynecologic Oncology Clinic at Doctor’s Hospital at Renaissance, Edinburg, TX, 2010 - 2013
Clinical Instructor, University of Texas Medical Branch at Galveston, Galveston, TX, 2005 - 2006
Extramural Institutional Committee Activities
MD Anderson Peer, UT MD Anderson Peer Supporters, The University of Texas MD Anderson Cancer Center, 2026 - Present
SGO Peer Supporter, SGO UT MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2026 - Present
Peer Supporter, UT MD Anderson Department of Surgery Peer Supporter, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, Transition Team Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2025
Co-Chair, Safety Committee at Galveston Campus, The University of Texas MD Anderson Cancer Center, 2023 - 2025
Member, UT MD Anderson Safety Committe, The University of Texas MD Anderson Cancer Center, 2020 - Present
Co-Chair, League City Operations Committee - League City HAL, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member of Medical Advisory Board, Judy's Mission Advisory Committee/Medical Advisory Board, The University of Texas MD Anderson Cancer Center, 2020 - Present
Committee, Resident Selection - UTMB Galveston, The University of Texas MD Anderson Cancer Center, 2017 - 2022
Committee, Graduate Medical Education - UTMB School of Medicine, UTMB, 2017 - 2022
Faculty Senate, Faculty Senate - UTMB Galveston, UTMB, 2017 - 2018
Committee, Professional Liability Review - UTMB Galveston, UTMB, 2016 - 2025
Committee, Academy of Master Teachers - UTMB Galveston, UTMB, 2016 - 2024
Committee, Academy of Master Teachers Advocacy - UTMB Galveston, UTMB, 2016 - 2024
Committee, Pharmacy and Therapeutics - UTMB Galveston, UTMB, 2016 - 2022
Member, Task Force - UTMB Galveston, UTMB, 2016 - 2017
Task Force, Medical Student Performance Evaluation - UTMB School of Medicine, UTMB, 2016 - 2017
Member, TIME Initiative: "Gestational Module" Curriculum Development - UTMB School of Medicine, UTMB, 2016 - 2017
Co-Chair, 3rd Year Clerkship - UTMB School of Medicine, UTMB, 2016 - 2017
Committee, Physician Healer Track Curriculum - UTMB School od Medicine, UTMB, 2015 - 2022
Committee, Department of Obstetrics and Gynecology Education - UTMB Galveston, UTMB, 2014 - 2022
Member, 3rd Year Clerkship - Committee - UTMB School of Medicine, UTMB, 2014 - 2017
Committee, Minimally Invasive Surgery - UTMB Galveston, UTMB, 2013 - 2021
Facilitator, Gynecologic Oncology Tumor Board - UTMB Galveston, UTMB, 2010 - 2025
Committee, Resident Selection - UTMB Galveston, UTMB, 2005 - 2007
Honors & Awards
| 2025 | UT MD Anderson 2025 Women in Medicine for The Arts of Healing |
| 2024 | Top 10% nationally among gynecologic oncologists on care experience related to CAHPS scores, CAH |
| 2022 | Top 1% nationally among gynecologic oncologists on care experience related to CAHPS scores, CAH |
| 2020 | Faculty Marshall, UTMB School of Medicine Commencement, Class of 2020 |
| 2018 | UTMB “5-star provider”, University of Texas Medical Branch at Galveston |
| 2018 | UTMB John P. McGovern Academy of Oslerian Medicine Excellence in Clinical Teaching Award 2018, University of Texas Medical Branch at Galveston |
| 2017 | University of Texas Distinguished Teaching Professor, University of Texas Medical Branch at Galveston |
| 2017 | UTMB Clinician of the Month, Academy of Master Clinicians |
| 2016 - 2024 | UTMB Academy of Master Teachers, University of Texas Medical Branch at Galveston |
| 2015 - 2017 | Houstonia Magazine “Top Doc” in Houston/Galveston |
| 2012 - 2024 | Frances Eastland Conally Professorship in Gynecologic Oncology |
| 2005 | TAOG Resident Research Day, 3rd Place Award |
| 2005 | ACOG District VII and VIII Joint Annual Meeting “George T. Schneider Award” Best Presentation |
| 2002 - 2006 | “Golden Apple” Medical Student Teaching Award, University of Texas Medical Branch at Galveston |
| 2001 - 2002 | Finalist, UTMB Intern of the Year |
| 1992 | cum laude, Bryn Mawr College |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2016. “Neuroendocrine Carcinoma of the Gynecologic Tract: presentation, prognosis and treatment response”. Conference. “Neuroendocrine Carcinoma of the Gynecologic Tract: presentation, prognosis and treatment response”. San Antonio, TX, US.
- 2016. “Retrospective review of chemoradiation in the preoperative or definitive management of locally advanced vulvar cancer”. Conference. “Retrospective review of chemoradiation in the preoperative or definitive management of locally advanced vulvar cancer”. San Antonio, TX, US.
- 2016. “Bilateral Salpingectomy: an opportunity for cancer Prevention?. Conference. “Bilateral Salpingectomy: an opportunity for cancer Prevention?. San Antonio, TX, US.
- 2016. “Using Modified Team Based Learning to teach complex topics in clerkship years: teaching gynecologic malignancies in an obstetrics and gynecology clerkship”. Conference. “Using Modified Team Based Learning to teach complex topics in clerkship years: teaching gynecologic malignancies in an obstetrics and gynecology clerkship”. Albuquerque, NM, US.
- 2010. "Oxaliplatin + capecitabine in combination with radiation therapy for treatment of cervical cancer: A phase II study". Conference. "Oxaliplatin + capecitabine in combination with radiation therapy for treatment of cervical cancer: A phase II study". San Fransico, CA, US.
- 2006. "Thromboembolic events in Patients Diagnosed with Cervical Carcinoma". Conference. "Thromboembolic events in Patients Diagnosed with Cervical Carcinoma". Palm Springs, CA, US.
- 2005. “Is DVT a prognostic marker for cervical cancer?. Conference. “Is DVT a prognostic marker for cervical cancer?, US.
- 2005. “Is DVT a prognostic marker for cervical cancer?”. Conference. “Is DVT a prognostic marker for cervical cancer?”. Austin, US.
International Presentations
- 2016. "Adjunct testosterone therapy improves cardiac function in cancer patients undergoing chemoradiotherapy". Conference. "Adjunct testosterone therapy improves cardiac function in cancer patients undergoing chemoradiotherapy". Seattle, US.
Formal Peers
- 2024. "GREOG Gynecologic Oncology Review". Galveston, Texas, US.
- 2023. "Epithelial ovarian cancers". Galveston, Texas, US.
- 2023. "Germ cell and gonadal stromal ovarian cancers". Galveston, Texas, US.
- 2023. "CREOG Genealogic Oncology Review". Galveston, Texas, US.
- 2022. "Molar pregnancy/gestational trophoblastic disease". Galveston, Texas, US.
- 2022. "Please don't kill me lectures: floor emergencies in gynecologic and gynecologic oncology patients". Galveston, Texas, US.
- 2022. "Goals of care: how to start difficult conversations". Galveston, Texas, US.
- 2022. "CREOG Gynecologic Oncology Review". Galveston, Texas, US.
- 2021. "Ovarian cancer: epithelial ovarian - current treatment options". Galveston, Texas, US.
- 2021. "Hospice/End of Life Care". Galveston, Texas, US.
- 2021. "Anticipatory Grie". Galveston, Texas, US.
- 2021. "CREOG Gynecologic Oncology Review". Galveston, Texas, US.
- 2020. "Endometrial cancer overview of biology and clinical trials". Galveston, Texas, US.
- 2020. "Finding equanimity in difficult situations". Galveston, Texas, US.
- 2020. "Difficult Conversations". Galveston, Texas, US.
- 2020. "CREOG Gynecologic Oncology Review". Galveston, Texas, US.
- 2019. "Genetics and Gynecologic Malignancies". Galveston, Texas, US.
- 2019. "Fluids, Electrolytes and Blood Products: Please don't kill me in lecture se". Galveston, Texas, US.
- 2019. "Endometrial Cancer: Current Recommendations, Controversies and Immunotherapy". Galveston, Texas, US.
- 2019. "CREOG Gynecologic Oncology Review". Galveston, Texas, US.
- 2018. "Ovarian Cancer: Pathology and treatment discussions - from the basics to new areas of research". Galveston, Texas, US.
- 2018. "Updates and common coding errors for Gynecology". Visiting. Galveston, TX, US.
- 2018. “The new biologics: Implications for gynecologic malignancies”. Visiting. Temple, TX, US.
- 2018. "Resident Debriefing: Complex cases and scenarios". Visiting. Galveston, TX, US.
- 2017. “Gestational Trophoblastic Neoplasia”. Visiting. Galveston, TX, US.
- 2017. "Getting the tough conversations right: An interactive session on breaking bad news with third year medical students at UTMB". Invited, US.
- 2017. "Increasing awareness of prevalence, screening mechanisms and resources for sexual assault and intimate partner violence patients among third year medical students at UTMB". Invited, US.
- 2017. “Difficult Conversations: Debriefing complex cases and scenarios”. Visiting. Galveston, TX, US.
- 2017. "Communications: Improving discussions and breaking bad news". Visiting. Galveston, TX, US.
- 2017. “Using modified team based learning to teach complex topics in clerkship years: Teaching gynecologic oncology to medical students”. Invited, US.
- 2017. “Gynecologic Tumors”. Visiting. Galveston, TX, US.
- 2017. “Breast Diseases”. Visiting. Galveston, TX, US.
- 2017. “CREOG Gynecologic Oncology Review”. Visiting. Galveston, TX, US.
- 2016. “Equanimity and Compassion, Part 2”. Visiting. Galveston, TX, US.
- 2016. “Equanimity and Compassion”. Visiting. Galveston, TX, US.
- 2016. “Genetic basis for gynecologic malignancies”. Visiting. Galveston, TX, US.
- 2016. “Gynecologic Tumors”. Visiting. Galveston, TX, US.
- 2016. “Breast Diseases”. Visiting. Galveston, TX, US.
- 2016. “CREOG Gynecologic Oncology review”. Visiting. Galveston, TX, US.
- 2015. “Vulvar and Vaginal Malignancy”. Visiting. Galveston, TX, US.
- 2015. “Basic Science, Biology and Genetics of Gynecologic Malignancies”. Visiting. Galveston, TX, US.
- 2015. “Updates in Cervical Cancer”. Visiting. Austin, TX, US.
- 2015. “Gestational Trophoblastic Neoplasia”. Visiting. Galveston, TX, US.
- 2015. “Why we do what we do: A review of major clinical trials in Gynecologic Oncology”. Visiting. Galveston, TX, US.
- 2015. "Influence of Adjuvant Glucocorticoid Therapy on Body Composition in Cancer Patients Undergoing Chemoradiotherapy". Visiting. Boston, MA, US.
- 2015. “Gynecologic Tumors”. Visiting. Galveston, TX, US.
- 2015. “Breast Diseases”. Visiting. Galveston, TX, US.
- 2015. “Gynecologic Anatomy: A Review”. Visiting. Galveston, TX, US.
- 2015. “Genetics and Gynecologic Malignancies”. Visiting. Galveston, TX, US.
- 2014. "Improvements in physical, functional and quality of life determinants with testosterone therapy: A prospective, double-blind, randomized, placebo-controlled trial in cachectic patients undergoing chemoradiotherapy for advanced or recurrent cervical or head/neck cancer". Visiting. Houston, TX, US.
- 2014. “Updates in care for endometrial cancer". Visiting. Galveston, TX, US.
- 2014. “Fluids, Electrolytes and Blood Products: Please don’t kill me lecture series”. Visiting. Galveston, TX, US.
- 2014. “Breast Diseases”. Visiting. Galveston, TX, US.
- 2014. “Gynecologic Tumors”. Visiting. Galveston, TX, US.
- 2013. “Gestational Trophoblastic Neoplasia”. Visiting. Galveston, TX, US.
- 2013. “Endometrial Cancer: Current Recommendations and Controversies”. Visiting. Houston, TX, US.
- 2013. “Gynecologic Tumors”. Visiting. Galveston, TX, US.
- 2013. “Breast Diseases”. Visiting. Galveston, TX, US.
- 2013. "CREOG Review: A review of high-yield material. Visiting. Galveston, TX, US.
Grant & Contract Support
| Date: | 2016 |
| Title: | Academy of Master Teachers Faculty Development and Educational Innovation |
| Funding Source: | University of Texas Medical Branch at Galveston |
| Role: | Program Leader |
| Date: | 2011 - 2014 |
| Title: | Gynecologic Oncology Group Clinical Trial |
| Funding Source: | UTMB |
| Role: | Co-PI |
Selected Publications
Peer-Reviewed Articles
- Hsu, CD, Yu, X, Richardson, G, Kuo, YF, Guo, F, Adekanmbi, V, Hoang, T, Sharma, P, Berenson, AB. Vaginal estrogen therapy utilization and associated outcomes in younger survivors of endometrial cancer. Menopause Publish Ahead of Print, 2026. e-Pub 2026. PMID: 41774009.
- Hsu CD, Carpenter RM, Richardson G, Guo F, Adekanmbi V, Hoang TN, Berenson AB. Utilization of fezolinetant for the treatment of moderate-to-severe vasomotor symptoms of menopause in a real-world setting. Menopause Publish Ahead of Print, 2026. e-Pub 2026. PMID: 41493963.
- Knisely A, Dai Y, Barlow GL, Lee S, Lawson B, Clark H, Fellman B, Yuan Y, Lu W, Lubo Julio IC, Lazcano RN, Chelvanambi M, Melendez B, Singh B, Singh B, Wani K, Chen J, Yeh CC, Gao J, Barnes S, Shi O, Khan KB, Serrano AG, Gomez-Bolanos LI, Scalise CB, Cheung SK, Dutta P, Velichko S, ElNaggar AC, Liu MC, Wilke RN, How J, Ramondetta LM, Boruta DM, Richardson G, Shafer A, Westin SN, Sims T, Sood AK, Ramirez PT, Lazar AJ, Soliman PT, Lu K, Haymaker CL, Solis Soto LM, Wargo JA, Grisham R, Wucherpfennig KW, Wang L, Jazaeri AA. Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities. Clin Cancer Res 31(19):4122-4135, 2025. e-Pub 2025. PMID: 40748258.
- Lamiman K, Wilhelm AB, Eyzaguirre E, Richardson G. Diagnostic Challenges and Long-term Outcomes of Neuroendocrine Carcinoma of the Cervix: A Case Series. Int J Gynecol Pathol 43(2):149-157, 2024. e-Pub 2024. PMID: 37922936.
- Wright TJ, Dillon EL, Durham WJ, Chamberlain A, Randolph KM, Danesi C, Horstman AM, Gilkison CR, Willis M, Richardson G, Hatch SS, Jupiter DC, McCammon S, Urban RJ, Sheffield-Moore M. A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women. J Cachexia Sarcopenia Muscle 9(3):482-496, 2018. e-Pub 2018. PMID: 29654645.
- Guo F, Hirth JM, Lin YL, Richardson G, Levine L, Berenson AB, Kuo YF. Authors' Response: "Angelina Jolie Effect" on the Shifting Role of BRCA Testing in the U.S. Am J Prev Med 53(5):e197-e199, 2017. e-Pub 2017. PMID: 29054247.
- Guo F, Hirth JM, Lin YL, Richardson G, Levine L, Berenson AB, Kuo YF. Use of BRCA Mutation Test in the U.S., 2004-2014. Am J Prev Med 52(6):702-709, 2017. e-Pub 2017. PMID: 28342662.
- Joyner M, Richardson G, Levine L, Hatch S. Retrospective review of chemoradiation in the preoperative or definitive management of locally advanced vulvar cancer. Oncology 29(4 Suppl 1), 2015. e-Pub 2015. PMID: 25930866.
- Ma LT, Campbell GA, Richardson G, Schnadig VJ. Should high-risk adolescents have Papanicolaou tests?. Cancer Cytopathol 121(8):432-9, 2013. e-Pub 2013. PMID: 23450854.
- Dillon EL, Basra G, Horstman AM, Casperson SL, Randolph KM, Durham WJ, Urban RJ, Diaz-Arrastia C, Levine L, Hatch SS, Willis M, Richardson G, Sheffield-Moore M. Cancer cachexia and anabolic interventions: a case report. J Cachexia Sarcopenia Muscle 3(4):253-63, 2012. e-Pub 2012. PMID: 22585408.
- Ramondetta LM, Urbauer D, Brown AJ, Richardson G, Thaker PH, Koenig HG, Levenback C, Sun C. Work related stress among gynecologic oncologists. Gynecol Oncol 123(2):365-9, 2011. e-Pub 2011. PMID: 21777966.
- Ramondetta L, Brown A, Richardson G, Urbauer D, Thaker PH, Koenig HG, Gano JB, Sun C. Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making. Int J Gynecol Cancer 21(3):573-81, 2011. e-Pub 2011. PMID: 21436706.
Abstracts
- Dillon EL, Durham W J, Casperson SL, Hortsman AM, Randolph KM, Danesi CP, Hatch SS, McCammon SD, Levine L, Willis M, Richardson G, Urban RJ, Sheffield-Moore M. Testosterone Therapy is Anti-Cachectic in Cancer Patients Receiving Standard of Care Chemotherapy. Journal of Geriatric Oncology 4:S21, 2013. e-Pub 2013.
- Hsu CD, Yu X, Kuo YF, Adekanmbi V, Guo F, Richardson G, Hoang TN, Sharma P, Berenson AB. The Utilization of Hormone Replacement Therapy and Associated Outcomes in Endometrial Cancer Survivors: a Propensity-Score Matched Cohort Study. American Society of Preventive Oncology (ASPO).
- Hsu CD, Carpenter R, Guo F, Adekanmbi V, Hoang TN, Richardson G, Berenson AB. Safety and Utilization of Fezolinetant for Menopause Symptoms. International Society for Pharmacoepidemiology (ISPE) Annual Meeting.
Book Chapters
- Levine L, G|| R. Cancer in Pregnancy. In: Maternal Medicine. McGraw Hill, 495-512, 2015.
- Levine L, Richardson G. Robotic Surgery for Ovarian Cancer. In: Robotic Surgery. Walter de Gruyter GmbH, 249-257, 2013.
- Richardson G, Dinh T. Ovarian Cancer Surgery. In: Gynecologic Surgery. McGraw-Hill Education, 187-199, 2011.
- Richardson G, Dinh T. Radical Hysterectomy. In: Gynecologic Surgery. McGraw-Hill Education, 201-213, 2011.
Patient Reviews
CV information above last modified August 07, 2026